Elucidation of pathologic condition in amyloidosis using C-11 PiB PET

Elucidation of pathologic condition in amyloidosis using C-11 PiB PET - Elucidation of pathologic condition in amyloidosis using C-11 PiB PET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043742

Enrollment

100

Registered

2021-03-25

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with or suspected amyloidosis

Interventions

PETCT imaging will be performed after injection of C-11 PiB.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with or suspected amyloidosis

Exclusion criteria

Exclusion criteria: Patient judged unsuitable as a subject by a researcher

Design outcomes

Primary

Measure	Time frame
SUV in amyloidosis using C-11 PiB PET	—

Countries

Japan

Contacts

Public ContactYuka Yamamoto

Faculty of Medicine, Kagawa University Department of Radiology

yamamoto.yuka@kagawa-u.ac.jp087-898-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026